Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ACTH Syndrome, Ectopic × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 36 Neoplasm Metastasis 17 Liver Neoplasms 16 Colorectal Neoplasms 13 Cholangiocarcinoma 11 Lung Neoplasms 9 Pancreatic Neoplasms 8 Colonic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 4 Pain 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Leiomyoma 3 Kidney Neoplasms 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2

Interventions

relacorilant 5 Osilodrostat 3 Mifepristone 3 Corlux 3 Metyrapone 2 pembrolizumab 1 pasireotide 1 Staining and Labeling 1 Radiofrequency Ablation 1 Forest Therapy 1 ASP3662 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02756754 2019-07-16

ADERADHTA

University Hospital, Toulouse

Phase NA Completed

ACTH Syndrome, Ectopic, Hyperaldosteronism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡